Presidential Panel Says High-Priced Cancer Drugs Harm Patient Care
TUESDAY, March 13, 2018 (HealthDay News) — “Financial toxicity” caused by high cancer drug prices is harming people’s ability to fight the dreaded disease, a new report from the President’s Cancer Panel warns. The report, released Tuesday, argues that urgent action is needed to stem the growing price tags associatedContinue Reading